[go: up one dir, main page]

AU2002242552A1 - Neotic and endoapoptotic cells and detection of neosis and endoapoptosis - Google Patents

Neotic and endoapoptotic cells and detection of neosis and endoapoptosis

Info

Publication number
AU2002242552A1
AU2002242552A1 AU2002242552A AU2002242552A AU2002242552A1 AU 2002242552 A1 AU2002242552 A1 AU 2002242552A1 AU 2002242552 A AU2002242552 A AU 2002242552A AU 2002242552 A AU2002242552 A AU 2002242552A AU 2002242552 A1 AU2002242552 A1 AU 2002242552A1
Authority
AU
Australia
Prior art keywords
neotic
endoapoptotic
endoapoptosis
neosis
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002242552A
Inventor
Rengaswami Rajaraman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dalhousie University
Original Assignee
Dalhousie University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dalhousie University filed Critical Dalhousie University
Publication of AU2002242552A1 publication Critical patent/AU2002242552A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • G01N33/5017Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity for testing neoplastic activity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU2002242552A 2001-03-30 2002-03-28 Neotic and endoapoptotic cells and detection of neosis and endoapoptosis Abandoned AU2002242552A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US82369201A 2001-03-30 2001-03-30
US09/823,692 2001-03-30
PCT/CA2002/000419 WO2002079504A2 (en) 2001-03-30 2002-03-28 Neotic and endoapoptotic cells and detection of neosis and endoapoptosis

Publications (1)

Publication Number Publication Date
AU2002242552A1 true AU2002242552A1 (en) 2002-10-15

Family

ID=25239431

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002242552A Abandoned AU2002242552A1 (en) 2001-03-30 2002-03-28 Neotic and endoapoptotic cells and detection of neosis and endoapoptosis

Country Status (2)

Country Link
AU (1) AU2002242552A1 (en)
WO (1) WO2002079504A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0741798A4 (en) * 1994-01-21 1998-07-29 Coulter Corp Solid tumor analysis by multiparametric flow cytometry
US6245501B1 (en) * 1996-12-02 2001-06-12 Dalhousie University Method for cancer screening
ATE546544T1 (en) * 1998-03-31 2012-03-15 Esoterix Genetic Lab Llc METHOD FOR DIAGNOSIS AND TREATMENT OF LUNG CANCER
CA2354270C (en) * 1998-12-10 2010-12-07 The Government Of The United States Of America Represented By The Secretary Of The Department Of Health And Human Services Designs for non-contact laser capture microdissection

Also Published As

Publication number Publication date
WO2002079504A3 (en) 2003-08-21
WO2002079504A2 (en) 2002-10-10
WO2002079504A9 (en) 2002-12-05

Similar Documents

Publication Publication Date Title
AU2002323210A1 (en) Bio-synthetic photostimulators and methods of use
AU2001288762A1 (en) Detection and characterization of microorganisms
AU2002248674A1 (en) Electrochemical sensor and method thereof
AU2003275311A1 (en) Solid micro-perforators and methods of use
AU2002314466A1 (en) Withasol and methods of use
AU2002343107A1 (en) Detection systems and methods
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002307054A1 (en) Detection of abnormal cells
AU2002341577A1 (en) Rapid and specific detection of campylobacter
AU2002366501A1 (en) Method of detection and enumeration of bacteria
AU2002363938A1 (en) Methods and use of motoneuronotropic factors
AU2002332028A1 (en) Preadipocyte cell strains and uses therefore
AU2001229530A1 (en) Detection of fermentation-related microorganisms
AU2002334186A1 (en) Production, detection and use of transformant cells
AU2003285686A1 (en) Glycoisoforms of adiponectin and uses thereof
GB0102717D0 (en) Cells and uses therefor
AU2002352696A1 (en) Cell substrates and methods of use thereof
AU2002245648A1 (en) Isogenic ss-catenin cell lines, and methods of making and using same
AU2003225799A1 (en) Tethered activity-based probes and uses thereof
AU2002242086A1 (en) Chemomagnetic retrieval of cmv and cmv infected cells
AU2002242552A1 (en) Neotic and endoapoptotic cells and detection of neosis and endoapoptosis
AUPQ826500A0 (en) Enzyme detection and measurement
AU2002325211A1 (en) Electrochemical cells and method of making the same
AU2002259238A1 (en) Dwf12 and mutants thereof
AU2002366640A1 (en) Detection and removal of lead using lead-binding proteins

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase